BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22005015)

  • 21. Forward genetic screening for regulators involved in cholesterol synthesis using validation-based insertional mutagenesis.
    Jiang W; Tang JJ; Miao HH; Qu YX; Qin J; Xu J; Yang J; Li BL; Song BL
    PLoS One; 2014; 9(11):e112632. PubMed ID: 25426949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyp3a deficiency enhances androgen receptor activity and cholesterol synthesis in the mouse prostate.
    Hashimoto M; Kobayashi K; Yamazaki M; Kazuki Y; Takehara S; Oshimura M; Chiba K
    J Steroid Biochem Mol Biol; 2016 Oct; 163():121-8. PubMed ID: 27137100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclic AMP-dependent proteolysis of GATA-6 expressed on the intracellular membrane.
    Tsuge T; Uetani K; Sato R; Ohashi-Kobayashi A; Maeda M
    Cell Biol Int; 2008 Feb; 32(2):298-303. PubMed ID: 18078765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SIK2 enhances synthesis of fatty acid and cholesterol in ovarian cancer cells and tumor growth through PI3K/Akt signaling pathway.
    Zhao J; Zhang X; Gao T; Wang S; Hou Y; Yuan P; Yang Y; Yang T; Xing J; Li J; Liu S
    Cell Death Dis; 2020 Jan; 11(1):25. PubMed ID: 31932581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
    Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
    Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The nuclear receptor FXR uncouples the actions of miR-33 from SREBP-2.
    Tarling EJ; Ahn H; de Aguiar Vallim TQ
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):787-95. PubMed ID: 25593129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel processing system of sterol regulatory element-binding protein-1c regulated by polyunsaturated fatty acid.
    Nakakuki M; Kawano H; Notsu T; Imada K; Mizuguchi K; Shimano H
    J Biochem; 2014 May; 155(5):301-13. PubMed ID: 24729033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of caveolin-1 expression can affect signalling through the phosphatidylinositol 3-kinase/Akt pathway and cellular proliferation in response to insulin-like growth factor I.
    Matthews LC; Taggart MJ; Westwood M
    Endocrinology; 2008 Oct; 149(10):5199-208. PubMed ID: 18583416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leishmania donovani activates SREBP2 to modulate macrophage membrane cholesterol and mitochondrial oxidants for establishment of infection.
    Mukherjee M; Basu Ball W; Das PK
    Int J Biochem Cell Biol; 2014 Oct; 55():196-208. PubMed ID: 25218172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus nonstructural 4B protein modulates sterol regulatory element-binding protein signaling via the AKT pathway.
    Park CY; Jun HJ; Wakita T; Cheong JH; Hwang SB
    J Biol Chem; 2009 Apr; 284(14):9237-46. PubMed ID: 19204002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SREBP transcription factors: master regulators of lipid homeostasis.
    Eberlé D; Hegarty B; Bossard P; Ferré P; Foufelle F
    Biochimie; 2004 Nov; 86(11):839-48. PubMed ID: 15589694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Akt signaling by exclusion from lipid rafts in normal and transformed epidermal keratinocytes.
    Calay D; Vind-Kezunovic D; Frankart A; Lambert S; Poumay Y; Gniadecki R
    J Invest Dermatol; 2010 Apr; 130(4):1136-45. PubMed ID: 20054340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive feedback loop between PI3K-Akt-mTORC1 signaling and the lipogenic pathway boosts Akt signaling: induction of the lipogenic pathway by a melanoma antigen.
    Yamauchi Y; Furukawa K; Hamamura K; Furukawa K
    Cancer Res; 2011 Jul; 71(14):4989-97. PubMed ID: 21632551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PI3K/AKT, JNK, and ERK pathways are not crucial for the induction of cholesterol biosynthesis gene transcription in intestinal epithelial cells following treatment with the potato glycoalkaloid alpha-chaconine.
    Mandimika T; Baykus H; Poortman J; Garza C; Kuiper H; Peijnenburg A
    J Agric Food Chem; 2008 Sep; 56(18):8745-52. PubMed ID: 18729378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoplasmic reticulum stress causes the activation of sterol regulatory element binding protein-2.
    Colgan SM; Tang D; Werstuck GH; Austin RC
    Int J Biochem Cell Biol; 2007; 39(10):1843-51. PubMed ID: 17604677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aβ inhibits SREBP-2 activation through Akt inhibition.
    Mohamed A; Viveiros A; Williams K; Posse de Chaves E
    J Lipid Res; 2018 Jan; 59(1):1-13. PubMed ID: 29122977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sterol-regulatory-element-binding protein 2 and nuclear factor Y control human farnesyl diphosphate synthase expression and affect cell proliferation in hepatoblastoma cells.
    Ishimoto K; Tachibana K; Hanano I; Yamasaki D; Nakamura H; Kawai M; Urano Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Doi T
    Biochem J; 2010 Jul; 429(2):347-57. PubMed ID: 20450493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceramide synthesis correlates with the posttranscriptional regulation of the sterol-regulatory element-binding protein.
    Worgall TS; Juliano RA; Seo T; Deckelbaum RJ
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):943-8. PubMed ID: 15132973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals.
    Hawkins JL; Robbins MD; Warren LC; Xia D; Petras SF; Valentine JJ; Varghese AH; Wang IK; Subashi TA; Shelly LD; Hay BA; Landschulz KT; Geoghegan KF; Harwood HJ
    J Pharmacol Exp Ther; 2008 Sep; 326(3):801-8. PubMed ID: 18577702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.